Trials / Unknown
UnknownNCT04349293
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Multicentric interventional prospective study with collection of biological samples as part of a routine care research
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Tissue sampling | Collection of a sample of tumor tissue and a sample of adjacent or counter lateral healthy tissue (if possible) from the surgical room |
| PROCEDURE | Blood sampling | Collection of a 30mL peripheral blood sample in heparin at several times: during surgical and medical treatment (before surgery, before the start of mAbs and after mAbs) |
Timeline
- Start date
- 2016-09-08
- Primary completion
- 2021-09-01
- Completion
- 2021-09-01
- First posted
- 2020-04-16
- Last updated
- 2020-04-16
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04349293. Inclusion in this directory is not an endorsement.